Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues.

作者: Pier G. Natali , Maria R. Nicotra , Aldo Bigotti , Irene Venturo , Dennis J. Slamon

DOI: 10.1002/IJC.2910450314

关键词:

摘要: The human homolog of the rat neu oncogene, HER2 (also termed c-erbB2) has been demonstrated in amplified form breast tumors with poor prognosis. Although amplification gene correlates expression a 185-kDa transmembrane glycoprotein, no extensive information is available regarding extent tissue and tumor specificity this product. We have addressed issue by immunohistochemically evaluating p185 normal various using monoclonal antibodies (MAbs) to distinct epitopes its extracellular domain. No detectable levels were found fetal tissues analyzed, exception renal tubules 2 out 3 specimens tested intestinal epithelium. In adult tissues, glycoprotein restricted number cell types, being heterogeneous among individuals histotypes. Among neoplasms assayed was expressed 46% primary cancers, 28% ovarian 30% colon rectum malignancies. male adenocarcinomas p185-positive. A large other revealed only low incidence p185. metastatic homogeneously multiple autologous lesions almost invariably (80%) lesion correlated that deriving metastases. Our findings indicate represents marker clinical relevance cancer. Whether holds true for malignancies remains be explored.

参考文章(24)
P. G. Natali, G. A. Scassellati, S. Ferrone, M. Salvatore, G. Paganelli, R. Masi, P. Riva, L. Troncone, G. L. Turco, A. G. Siccardi, L. Callegaro, G. L. Buraggi, V. Caputo, A. Abbati, M. Sanguineti, M. Bestagno, L. Mansi, G. Mariani, Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Research. ,vol. 46, pp. 4817- 4822 ,(1986)
R M Hudziak, G D Lewis, M Winget, B M Fendly, H M Shepard, A Ullrich, p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Molecular and Cellular Biology. ,vol. 9, pp. 1165- 1172 ,(1989) , 10.1128/MCB.9.3.1165
R. M. Hudziak, J. Schlessinger, A. Ullrich, Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 84, pp. 7159- 7163 ,(1987) , 10.1073/PNAS.84.20.7159
D.A. Spandidos, M.L.M. Anderson, A study of mechanisms of carcinogenesis by gene transfer of oncogenes into mammalian cells (MTR 07215) Mutation Research/Reviews in Genetic Toxicology. ,vol. 185, pp. 271- 291 ,(1987) , 10.1016/0165-1110(87)90020-0
A. Jakobovits, G. M. Shackleford, H. E. Varmus, G. R. Martin, Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 83, pp. 7806- 7810 ,(1986) , 10.1073/PNAS.83.20.7806
C. Russo, L. Callegaro, E. Lanza, S. Ferrone, Re.: Purification of IgG monoclonal antibody by caprylic acid precipitation. Journal of Immunological Methods. ,vol. 65, pp. 269- 271 ,(1983) , 10.1016/0022-1759(83)90324-1
P. Di Fiore, J. Pierce, M. Kraus, O Segatto, C. King, S. Aaronson, erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells Science. ,vol. 237, pp. 178- 182 ,(1987) , 10.1126/SCIENCE.2885917
M. Mottolese, I. Venturo, R. Perrone Donnorso, C. Gallo Curcio, M. Rinaldi, P.G. Natali, Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin. European Journal of Cancer and Clinical Oncology. ,vol. 24, pp. 1277- 1284 ,(1988) , 10.1016/0277-5379(88)90215-5